Author pages are created from data sourced from our academic publisher partnerships and public sources.
Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study.
- G. Goldenberg, T. Karagiannis, +5 authors D. Siegel
- Journal of the American Academy of Dermatology
- 1 November 2016
BACKGROUND Accurate evaluation of basal cell carcinoma (BCC) in the United States was not possible before the 2011 release of BCC-specific International Classification of Diseases, Ninth Revision,… Expand
Healthcare Resource Use and Direct Costs in Patients with Ankylosing Spondylitis and Psoriatic Arthritis in a Large US Cohort
- Jeffrey D Greenberg, Jacqueline B. Palmer, Y. Li, V. Herrera, Yuen Tsang, Minlei Liao
- The Journal of Rheumatology
- 1 January 2016
Objective. Direct costs of ankylosing spondylitis (AS) and psoriatic arthritis (PsA) have not been well characterized in the United States. This study assessed healthcare resource use and direct cost… Expand
Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial
Despite the clinical benefit of statin therapy and the numerous strategies used to improve adherence, no strategy has used direct communication of genetic test results to the patient as an adherence… Expand
Clinical Characteristics, Disease Activity, and Patient‐Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis…
To characterize psoriatic arthritis (PsA) patients with dactylitis or enthesitis and evaluate the associations of these manifestations with disease activity and patient‐reported outcomes.
Out-of-pocket drug costs and drug utilization patterns of postmenopausal Medicare beneficiaries with osteoporosis.
- L. Conwell, D. Esposito, +6 authors M. Marciniak
- The American journal of geriatric pharmacotherapy
- 1 August 2011
BACKGROUND The Medicare Part D coverage gap has been associated with lower adherence and drug utilization and higher discontinuation. Because osteoporosis has a relatively high prevalence among… Expand
Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes
- R. Aubert, V. Herrera, W. Chen, S. M. Haffner, M. Pendergrass
- Diabetes, obesity & metabolism
- 1 August 2010
Aim: The objectives of the study were to determine whether thiazolidinedione (TZD) use is associated with an increased risk of fracture in men and women with type 2 diabetes mellitus and to compare… Expand
Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year.
- K. Johnson, H. Zhou, F. Lin, J. Ko, V. Herrera
- Journal of managed care & specialty pharmacy
- 24 July 2017
BACKGROUND Disease-modifying therapies (DMTs) are indicated to reduce relapse rates and slow disease progression for relapsing-remitting multiple sclerosis (MS) patients when taken as prescribed.… Expand
Children and Adults With Frequent Hospitalizations for Asthma Exacerbation, 2012-2013: A Multicenter Observational Study.
- K. Hasegawa, Jane C. Bittner, +5 authors C. Camargo
- The journal of allergy and clinical immunology…
- 1 September 2015
BACKGROUND Earlier studies reported that many patients were frequently hospitalized for asthma exacerbation. However, there have been no recent multicenter studies to characterize this patient… Expand
Statin use in asthmatics on inhaled corticosteroids is associated with decreased risk of emergency department visits
Abstract Objective: Statins are hypothesized to have beneficial effects in asthma management through their pleiotropic anti-inflammatory effects. Several studies have examined this relationship, but… Expand
Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis
- Jacqueline B. Palmer, Y. Li, V. Herrera, Minlei Liao, M. Tran, Z. Ozturk
- BMC Musculoskeletal Disorders
- 14 June 2016
BackgroundReal-world data regarding anti-tumor necrosis factor alpha (anti-TNFα) biologic therapy use in psoriatic arthritis (PsA) are limited; therefore, we described treatment patterns and costs of… Expand